Article

Oncology on Canvas Winner's Cancer Experience Shapes Her Artwork

Susan Hope Schaffer, the 2014 Oncology on Canvas overall winner, shares how her experience with breast cancer helped her evolve as an artist.

Susan Hope Schaffer, this year's Oncology on Canvas overall winner, shares how her experience with breast cancer has helped her evolve as an artist. Her piece, "Visions of Hope," highlights how her medical team, family and other cancer survivors gave her hope through diagnosis and treatment.

"My cancer journey has gone from some pain and anguish to a beautiful result, and that's the artwork that I've created," she says. Schaffer wants her artwork, which she has submitted to the Oncology on Canvas art competition since 2008, to give hope and energy to others going through cancer.

Schaffer, who is from Bethlehem, Pa., said the competition has given her a voice over the years to document her journey, including appreciation, fear and anger. This year's piece, she says, shows the hope she's gained from her cancer experience. "Visions of Hope," along with hundreds of other submissions to this year's competition, will be on display throughout the United States in a traveling art exhibit beginning in early 2015.

[Watch "Oncology on Canvas and The Hope Murals Project Reaches New York City"]

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Related Content